IRISH VENTURE CAPITAL ASSOCIATION. Ireland THE INVESTMENT OPPORTUNITY

Similar documents
Debt & Equity A Match Made in Heaven? The Investor s Perspective. Colin Walsh

CDP-EIF ITAtech Equity Platform

Israel Venture Capital Investments Report Q3 2017

Overview of Venture Equity

Globalisation increasingly affects how companies in OECD countries

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

ACCESS TO FINANCING FOR SMEs Problems and Challenges. Prof. dr Dejan Erić Belgrade Banking Academy Member of the ERENET Network 2005.

2014 Global venture capital confidence survey results

2013 Global venture capital confidence survey results. How confident are investors?

Best practice case study

Venture capital - An introduction into the nature of venture capital

National Innovation Systems: Implications for Policy and Practice. Dr. James Cunningham Director. Centre for Innovation and Structural Change

Private Equity and Venture Capital in Switzerland

KTO co-operation with venture capitalists how to design effectively?

SUPPORTING ROLL-OUT OF INNOVATIVE SOLUTIONS

ITRE Committee European Parliament Hearing on Horizon Chiara de Caro, EBAN General Manager March 20 th 2012

Health & Social Care Industrial Innovation

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

The European Investment Fund & Technology Transfer. Future Internet Assembly, Dublin 8 May 2013 Dr. Piyush Unalkat

Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Moore Thompson: the corporate finance experts

Peter C. Freeman has over 40 year s experience in financial management, creating financial infrastructure and raising capital for established, startup,

Forum Science & Business FCRi - EY Foundation

SESSION 4: Mr. Hanson Cheah, Managing Partner, AsiaTech Ventures Limited, Hong Kong

EVCA Strategic Priorities

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018

We would be delighted to discuss your needs and how we could support you, so please get in touch. Our contact details appear on the final page.

KIC EIT Raw Materials

4 th Quarter Earnings Conference Call

T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T AND PRIVATE EQUITY ENERGIZE GROWTH

Inbound Flip Transactions

Guidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation

Robert A. Greising Partner

Spring 2008 Participating VC firms

IDEO PROJECT. Venture Capital & Private Equity LATVIA

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

Robert A. Greising Partner

Annual Report 2010 COS T SME. over v i e w

EIF Equity Products. Finland 5 February 2015

QANTM Intellectual Property Limited (ASX: QIP)

Theme 3: Supporting the opportunities in the EU robotics sector: inputs for an industrial policy for robotics

A Science & Innovation Audit for the West Midlands

9 Vaccine SMEs' Needs

Dynamic Cities and Creative Clusters

Public Research and Intellectual Property Rights

Venture Capital Search Highlights

Surrey Knowledge Transfer Account

GOVERNMENT PROMOTION OF HIGH- POTENTIAL ENTREPRENEURSHIP AND VENTURE CAPITAL

ESban Financing Innovation in SMEs: the role of Business Angels 11 th December 2009, Madrid

GLOBAL & LOCAL INVESTMENT TRENDS

Financing Emerging Growth Companies

APEC Internet and Digital Economy Roadmap

VentureSource U.S. -- 4Q 2013

OECD-INADEM Workshop on

GREATER MONTRÉAL Life Sciences & Health Tech hub

executives are often viewed to better understand the merits of scientific over commercial solutions.

Building an enterprise-centred innovation system

4 th Quarter Earnings Conference Call

Angel Investor Networks The Power of Groups

TRANSFORMATION INTO A KNOWLEDGE-BASED ECONOMY: THE MALAYSIAN EXPERIENCE

Enabling investment: general factors

EIF Technology Transfer Activities. JRC Round Table Brussels, 11 April 2013 Marc Schublin

Getting Started. This Lecture

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

Stakeholder engagement

2013 venture capital trends summary

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

Research Patents in Biotech SMEs

Innovation Management & Technology Transfer Innovation Management & Technology Transfer

University of Oxford Executive Finance Programmes

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017

What is InnovFin Equity?

Funding & Patents. Enterprise & Project Management

MoneyTreeTM. Report. Some $171 million VC financing invested in hi-tech companies in Q compared with $255 million in the second quarter 2012

British Business Bank

Talk: How companies successfully partner with Irish Universities - Industry Engagement at Trinity College Dublin

4 th Quarter Earnings Conference Call

OECD/ADBI 7th Round Table on Capital Market Reform in Asia October 2005 ADB Institute, Tokyo, Japan

ISRAEL FROM ORANGES TO APPLE

Amadeus. Private Equity and Venture Capital Forum Argentina. Venture Capital in Emerging markets 1 July 2016

VENTURE CAPITAL USAGE AND ITS STAGES

The business of Intellectual Property

FINC915 Venture Lab Participating Firms: FALL 2010

2 nd Quarter Earnings Conference Call

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

Testimony to European Parliament

HOTELS, TOURISM & LEISURE. Hotels, Tourism & Leisure

4 th Quarter Earnings Conference Call

Conclusions on the future of information and communication technologies research, innovation and infrastructures

Managing the New Trajectory of Global Innovation

Rehab Group Board Members Appointed 8 September 2014

PANEL DISCUSSION & ROUNDTABLES

Venture Capital. Structuring Deals & The Investment Process

IP Strategies to Enhance Competitiveness: India s Experience

D.T Benchmarking Report

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

MEASURES TO SUPPORT SMEs IN THE EUROPEAN UNION

NSW Digital+ Public Consultation

Transcription:

IRISH VENTURE CAPITAL ASSOCIATION Ireland THE INVESTMENT OPPORTUNITY

The Venture Capital Industry in Ireland Ireland A GATEWAY TO EUROPE The 2011 IBM Global Location Trends Report has named Ireland as the top destination in the world for foreign direct investment. US investment into Ireland exceeds the combined total into Brazil, Russia, China and India. Key attributes Skilled workforce that is young, well educated and flexible. Favourable business environment. Competitive and transparent tax regime. Cluster/sectoral strengths particularly in the technology space. Companies located in Ireland include 8 of the top 10 US technology companies. 10 of the top Born on the Internet companies. 9 of the top 10 US Pharma companies. 11 of the top 13 medical technology companies. 50% of the world s leading financial services companies. Innovation and entrepreneurial activity 1st globally for exchange of technology and ideas. 2nd in Europe for the rate of entrepreneurial activity. Irish engineers developed the successful internet game Call of Duty Black Ops and created many award winning animation productions. Irish engineers created the drill that helped free 33 trapped Chilean miners. The global leader in the drug-eluting coronary stent market was researched, developed and commercialised in Ireland. There are 5200 Irish technology companies operating in the biomedical, pharmaceutical, software and green energy sectors. Software Ireland s fastest growing sector with particular emphasis on analytics, electronic devices, digital media including animation and gaming, cloud computing and healthcare technologies.

Venture Capital in Ireland Venture Capital, over the last twenty-five years, has played a critically important role in Irish economic development. The existing industry structure of independently funded limited partnerships began to emerge in the mid-1990s and is now in its third investment cycle. Since 1997 the number of VC funds operating in Ireland has more than doubled and the average size of VC funds has increased from 20m to 90m. Irish VC Funds have now reached the critical mass needed to allow sufficient diversification to spread portfolio risk. Investment Expertise Irish VCs have extensive experience and have invested in a wide range of deal types from early stage technology companies, to R&D commercialisation and to companies requiring later stage development capital. In recent years many of the funds have diversified geographically into the UK, US and into mainland Europe. Governance, Tax and Legal Structure: Most attractive European Location The tax and legal structure has been benchmarked by the European Venture Capital Association (EVCA) and they conclude that Ireland is currently the 2nd most favoured country in Europe for international VC activity. Support is available from state and local government in the form of favourable tax policies, common-sense regulatory structures and encouragement of basic research. Ireland s tax regime recognises the importance of capital formation and rewards long-term investment in innovation. The limited partnership structure ensures tax transparency. Carried interest is taxed as a capital gain at 12.5%. The R&D tax credit regime and the IP regime are second to none. Irish VCs abide by the governance and valuation guidelines as recommended by the EVCA. In addition Ireland has developed a strong network of lawyers, accountants and other business professionals that understand the challenges of the start-up community and are essential to building a viable venture capital hub. These networks provide start-ups and VCs with specialised services including intellectual property protection, M&A and tax advice, auditing and workforce development. Why Now? Reputation for Technology Development The focus of venture capital activity is on investment in high technology early stage companies in the information and computer technology and the life sciences sectors. Over 600 of these companies have been supported by Irish VCs in the last ten years. Ireland is now established as a major force in technology development. Industry specialities that have emerged include medical devices, gaming, cloud computing and telecoms software. Reasonable Valuation Early stage valuations are stable after dropping significantly with the onset of the global financial crisis, while later stage and exit valuations are growing. Scaling Opportunities Companies, through the internet, have global reach, and are scaling faster and accruing value earlier. Strong M&A M&A activity is strong, leading to attractive exit opportunities for VC investors. Strong Exit Market The ecosystem provides a vibrant exit mechanism for entrepreneurs and venture capitalists. Most exits in Ireland are through trade sales mainly to multinationals, thus further expanding the presence of the multinational industry in Ireland. In the five years from 2007 the average size of a trade sale exit has increased from 32m to 115m.

Deal Flow There has been a surge in the quantity and quality of the deal pipeline enabling an expansion of the venture capital industry. There are three sources of deals: Commercialising 3rd level R&D: Spin-outs The development agencies in Ireland are improving the quality of the public research infrastructure and promoting its links to industry in order to transfer knowledge from research organisations to the market. Specific initiatives include: the establishment of Science Foundation Ireland (SFI) Centres for Science, Engineering and Technology (CSET) with the aim of significantly advancing knowledge and exploiting opportunities for discovery and innovation. linking academic researchers and industry within Strategic Research Clusters (SRC) that focus on aspects of the ICT and life sciences industries. Enterprise Ireland is working closely with these research centres to encourage and facilitate commercialisation of ideas and technologies by supporting the emergence of spin-outs. The number of new start-up companies from this source is growing year on year. Commercialising Corporate R&D: Spin-outs The presence of innovative, international publicly quoted companies with an entrepreneurial emphasis and talented people (e.g. Google, Hewlett Packard, Intel, Yahoo, Paypal, Zynga and Facebook) is another encouraging source of entrepreneurs and start-up companies. Incremental Pipeline: New Seed Funds The number of Irish companies raising venture capital has doubled from 82 in 2007 to 159 per year in 2011. Within this cohort the number of start-ups has increased from 17 per year to 63 per year. The establishment of Seed Funds, funded by Enterprise Ireland and the banking sector and managed by the domestic VCs, has created a significant incremental pipeline of up to 200 early stage companies with high growth potential. All of these will require venture capital to fund development. The IVCA estimates that the capital required to fund innovative Irish SMEs is 1.5bn, i.e. 300m per annum over the next five years. This demand will create significant investment opportunities. The government has specifically identified medical technology as an area of strategic importance. The Irish government is putting its money where its mouth is, with a strong investment initiative. At the same time Ireland s private sector is stepping up, with a growing venture capital presence and apparently no lack of entrepreneurs with new ideas for innovative technology... a host of medical device companies that sprang up creating a medtech cluster rivalling those in Israel and areas in the US like San Francisco, Minneapolis, Orange County and Boston. Vivasure Medical Ltd is an example of what might be called the new breed of Irish medical device start-up: a sophisticated technology serving major emerging markets from a company run by experienced executives with a track record of success After raising money, the hardest part of doing a start up is finding the right people, says Jim Greene of Apica Cardiovascular Inc, the depth of knowledge in Galway is really deep. Irish surgeons have been working on developing medical technology for a long time, they have the right attitude, they understand taking risk and they like to be involved in projects that are innovative. September 2011: Vol 29, No 8: IN VIVO: THE BUSINESS & MEDICINE REPORT www.elsevierbl.com

FUNDING THE INDUSTRY Funding Structure The Irish Venture Capital Fund (IVCF) The IVCF is a Qualifying Investor Fund (QIF). In terms of structure, the QIF is a regulated, specialist investment fund targeted at sophisticated and institutional investors, who must meet minimum subscription ( 100,000) and financial resources requirements. The main advantage of the QIF is the removal of the Financial Regulator s general conditions relating to investment policies and borrowing, thereby enabling sophisticated investors to use this structure for a wide range of investment purposes. It is tax efficient (a) Irish investment funds are exempt from Irish tax on their income and gains, irrespective of where their investors are resident and (b) No withholding taxes apply on income distributions or on redemption payments made by a QIF to non-irish resident investors. The QIF is the preferred structure used in the regulated alternative investment sphere. KEY FEATURES Legal Structure The Company will be an umbrella investment company with variable capital and with segregated liability between sub-funds. The Company will be incorporated with limited liability in Ireland and will be authorised by the Central Bank of Ireland as an investment company pursuant to Part XIII of the Companies Act 1990. Investment Strategy The investment strategy of the IVCF will be determined by the Directors of the Company in conjunction with the investment committee and the investment manager. Shareholders/Investors Investors in the Company will be admitted as Shareholders and, subject to applicable Irish law, will receive the protection of limited liability, i.e. they will not be liable for the debts or obligations of the Company beyond the amount they have contributed to the Company. Key Benefits Diversified exposure to the next round of Irish venture capital investment. Tax efficient and transparent structure. Administrative efficiency. Potential for some secondary liquidity in the medium term.

VENTURE CAPITAL IN IRELAND Ireland is ranked 2nd in the EU for Venture Capital infrastructure and supports. Venture capital annual investment in Ireland increased by 42% between 2007 and 2011. Over 600 companies raised 1.3bn in this period High technology companies account for over 90% of venture capital investment in Ireland compared to a weighting of 31% in Europe. Investment in innovation is rewarded by R&D tax credits (25%) and by a low rate of capital gains tax on carried interest (12.5%). Irish Venture Capital Funds (Profiles) Pan European Funds (7 Funds, 800m under management) FUNDS SECTOR FOCUS WEB ADDRESS ACT Venture Capital Ltd ICT/Healthcare/Business Start-up/Expansion stage www.actventure.com & Consumer Services in IRL/UK/US Atlantic Bridge LP Semiconductor/ Growth/Buyout stage in www.abven.com Communications/Software IRL/EU/US Delta Partners ICT/Healthcare Start-up/Expansion stage in www.deltapartners.com IRL/UK/EU. DFJ Esprit ICT/Healthcare/Business & Growth/Buyout Stage in www.dfjesprit.com Consumer Services IRL/UK/EU ESB Novusmodus Cleantech/Energy Start-up/Expansion stage in www.novusmodus.com Efficiency IRL/UK/EU. Fountain Healthcare Life Sciences Start-up/Expansion stage in www.fh-partners.com IRL/EU/US Seroba Kernel Life Sciences Life Sciences Start-up/Expansion in IRL/UK/EU. www.seroba-kernel.com Irish Funds (7 Funds, 500m under management) 4th Level Venture University All Sectors 3rd level research www.4lv.ie Seed Fund LP commercialisation in IRL Dublin BIC All Sectors Start-up/Expansion stage in IRL. www.dbic.ie Enterprise Equity All Sectors Start-up/Expansion stage www.enterpriseequity.ie Venture Capital Group in IRL. Kernel Capital All Sectors Start-up/Expansion stage in IRL. www.kernelcapital.ie NCB Ventures All Sectors Start-up/Expansion/MBO stage in IRL. www.ncb-ventures.com TVC Holdings Plc All Sectors Distressed/Recovery opportunities in IRL. www.tvc.com Western Development All Sectors Start-up/Expansion stage in IRL www.wdc.ie Commission Investment Fund (Regional). Irish Venture Capital Association 3 Rectory Slopes, Bray, Co. Wicklow, Ireland T: +353 1 276 4647 F: +353 1 274 5915 E: secretary@ivca.ie www.ivca.ie